However, the group of CBF AML is heterogeneous in terms of additional cytogenetic abnormalities (ACAs) and associated gene mutations, with relevant differences between RUNX1::RUNX1T1 and CBFB::MYH11 AML [48,49,50]. The gene discussed is CEBPZ; the disease is acute myeloid leukemia.